Log In
BCIQ
Print this Print this
 

AV-101, L-4-chlorokynurenine

Also known as: 4-CI-KYN

  Manage Alerts
Collapse Summary General Information
Company VistaGen Therapeutics Inc.
DescriptionNMDA receptor antagonist
Molecular Target NMDA receptor
Mechanism of ActionNMDA receptor antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/23/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today